poisar

Stocks · News reference

Phoenix Education Partners, Pentair And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

BenzingaAvi Kapoor

US stock futures mostly higher, Nasdaq up by 100 points. Phoenix Education falls after cutting sales guidance. Other stocks also down in pre-market.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Zacks Investment ResearchNa

    Can Centene Sustain Its Turnaround Amid Membership Pressure?

    Centene Corporation reported Q2 2026 adjusted EPS of $2.51, marking a significant recovery from a loss a year prior, driven by improved medical cost trends and better execution. The company expects Medicaid membership to decline 8%-9% in 2026, but profitability improvements in Marketplace and Medicare segments, combined with higher Medicaid rates and cost initiatives, support continued recovery. CNC reaffirmed its 2026 adjusted EPS guidance above $4.80.

  2. Zacks Investment ResearchNa

    IQVIA Stock Rises 60% in 6 Months: Here's What You Should Know

    IQVIA (IQV) has surged 60.1% over six months, driven by 6% organic growth in Q2 2026, with R&DS bookings up 19.3% and a $34.2 billion backlog. The company's rapid AI adoption—294 agents deployed across 90 use cases with 19 of top 20 pharma companies adopting solutions—is strengthening its competitive position and supporting sustained growth.

  3. Zacks Investment ResearchNa

    Is Invesco S&P 500 Pure Value ETF (RPV) a Strong ETF Right Now?

    The Invesco S&P 500 Pure Value ETF (RPV) is a smart beta ETF with $1.75 billion in assets that tracks the S&P 500 Pure Value Index. It has delivered 19.31% year-to-date returns and 26.47% over the past year with a 0.35% expense ratio. The fund holds 125 stocks with heavy exposure to Financials (20.4%), Healthcare, and Consumer Staples sectors. While RPV offers reasonable value-focused exposure, cheaper alternatives like Vanguard's VTV (0.03% expense ratio) and Schwab's SCHD (0.06% expense ratio) may be more cost-effective for investors.

  4. Zacks Investment ResearchZacks.Com

    Here's How CVS' Health Services Arm Is Positioned for Long-Term Growth

    CVS Health's Health Services segment demonstrated strong Q2 2026 performance with revenues rising 11.5% to $51.8B and adjusted operating income climbing 10%. Health Care Delivery revenues jumped nearly 23% driven by Oak Street Health, while Pharmacy Services benefited from favorable drug mix and strong new sales of $6B. The company maintained its full-year 2026 outlook despite 340B program adjustments.

  5. Zacks Investment ResearchNa

    Can Centene's Medicare Advantage Strategy Unlock Better Margins?

    Centene Corporation is simplifying its Medicare Advantage footprint and emphasizing dual-eligible members to improve portfolio quality and margins. The company's Medicare segment health benefits ratio improved to 89.5% in Q2 2026, with MA moving closer to breakeven. For 2027, Centene aims to achieve breakeven or better MA results through medical-cost control, Stars execution, and SG&A management.